Literature DB >> 6940825

The occurrence of the philadelphia chromosome in essential thrombocytosis.

B R Rajendra, M Lee, M J Nissenblatt, G Gartenberg, D V Rose, L J Sciorra.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 6940825     DOI: 10.1007/bf00274681

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


× No keyword cloud information.
  10 in total

1.  Hemorrhagic thrombocythemia: a critical review.

Authors:  F W GUNZ
Journal:  Blood       Date:  1960-05       Impact factor: 22.113

2.  Editorial: The role of cytogenetics in hematology.

Authors:  J D Rowley
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

3.  Philadelphia-chromosome-positive preleukaemic state.

Authors:  G P Canellos; J Whang-Peng
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

Review 4.  Chromosomal abnormalities in human neoplasia.

Authors:  A A Sandberg; D K Hossfeld
Journal:  Annu Rev Med       Date:  1970       Impact factor: 13.739

5.  Primary haemorrhagic thrombocythaemia with Philadelphia chromosome.

Authors:  M L Ghosh
Journal:  Postgrad Med J       Date:  1972-11       Impact factor: 2.401

6.  Primary thrombocythemia. Clinical, hematological and chromosomal studies of 13 patients.

Authors:  P G Frick
Journal:  Helv Med Acta       Date:  1969-05

7.  Chromosome studies in potentially leukaemic myeloid disorders.

Authors:  M K Jensen
Journal:  Acta Med Scand       Date:  1968-06

8.  A chromosomal abnormality in primary thrombocythemia.

Authors:  A Zaccaria; S Tura
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

9.  Ph1-positive megakaryoblastic leukemia.

Authors:  D K Hossfeld; D Tormey; R R Ellison
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

10.  Evidence that chromosome band 22q12 is concerned with cell proliferation in chronic myeloid leukaemia.

Authors:  P H Fitzgerald
Journal:  Hum Genet       Date:  1976-08-30       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.